| Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes B Belandia, RL Orford, HC Hurst, MG Parker The EMBO journal 21 (15), 4094-4103, 2002 | 305 | 2002 |
| Hey1, a mediator of notch signaling, is an androgen receptor corepressor B Belandia, SM Powell, JM García-Pedrero, MM Walker, CL Bevan, ... Molecular and cellular biology, 2005 | 154 | 2005 |
| Nuclear receptors: a rendezvous for chromatin remodeling factors B Belandia, MG Parker Cell 114 (3), 277-280, 2003 | 153 | 2003 |
| Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors B Belandia, MG Parker Journal of Biological Chemistry 275 (40), 30801-30805, 2000 | 147 | 2000 |
| Thyroid hormone negatively regulates the transcriptional activity of the β-amyloid precursor protein gene B Belandia, MJ Latasa, A Villa, A Pascual Journal of Biological Chemistry 273 (46), 30366-30371, 1998 | 133 | 1998 |
| The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells JM García-Pedrero, E Kiskinis, MG Parker, B Belandia Journal of biological chemistry 281 (32), 22656-22664, 2006 | 116 | 2006 |
| Thyroid hormones regulate β-amyloid gene splicing and protein secretion in neuroblastoma cells MJ Latasa, B Belandia, A Pascual Endocrinology 139 (6), 2692-2698, 1998 | 99 | 1998 |
| Notch signaling: a potential therapeutic target in prostate cancer MA Villaronga, CL Bevan, B Belandia Current cancer drug targets 8 (7), 566-580, 2008 | 63 | 2008 |
| P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy DM Fernández-Aroca, O Roche, S Sabater, R Pascual-Serra, ... Cancer Letters 451, 23-33, 2019 | 52 | 2019 |
| Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors DN Lavery, MA Villaronga, MM Walker, A Patel, B Belandia, CL Bevan Journal of Biological Chemistry 286 (20), 17796-17808, 2011 | 47 | 2011 |
| A response unit in the first exon of the β-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3, 5, 3 … A Villa, J Santiago, B Belandia, A Pascual Molecular Endocrinology 18 (4), 863-873, 2004 | 45 | 2004 |
| The transcription factor CREBZF is a novel positive regulator of p53 I López-Mateo, MÁ Villaronga, S Llanos, B Belandia Cell cycle 11 (20), 3887-3895, 2012 | 38 | 2012 |
| HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions MA Villaronga, DN Lavery, CL Bevan, S Llanos, B Belandia Oncogene 29 (3), 411-420, 2010 | 32 | 2010 |
| Identification of BAF57 mutations in human breast cancer cell lines E Kiskinis, JM García-Pedrero, MA Villaronga, MG Parker, B Belandia Breast cancer research and treatment 98, 191-198, 2006 | 31 | 2006 |
| Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion L Serrano-Oviedo, M Ortega-Muelas, J Garcia-Cano, ML Valero, ... PLoS One 13 (7), e0200878, 2018 | 28 | 2018 |
| Down Regulation of C-MYC and MAX Genes Is Associated to Inhibition of Protein Phosphatase 2A in K562 Human Leukemia Cells A Lerga, B Belandia, MD Delgado, MA Cuadrado, C Richard, JM Ortiz, ... Biochemical and biophysical research communications 215 (3), 889-895, 1995 | 23 | 1995 |
| Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus B Belandia, D Brautigan, J Martín-Pérez Molecular and cellular biology, 1994 | 23 | 1994 |
| Mechanisms of androgen receptor repression in prostate cancer SM Powell, GN Brooke, HC Whitaker, V Reebye, SC Gamble, D Chotai, ... Biochemical Society Transactions 34 (6), 1124-1127, 2006 | 21 | 2006 |
| HEY1 functions are regulated by its phosphorylation at Ser-68 I López-Mateo, A Arruabarrena-Aristorena, C Artaza-Irigaray, JA López, ... Bioscience Reports 36 (3), e00343, 2016 | 14 | 2016 |
| Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient MÁ Villaronga, I López-Mateo, L Markert, E Espinosa, JÁ Fresno Vara, ... Breast cancer research and treatment 128, 891-898, 2011 | 14 | 2011 |
Bevan, C*Imperial College LondonVerified email at imperial.ac.uk
